Moreover, there is a variability related to the different assays of FGF23 used in terms of sensitivity and/or specificity, and unknown timing of the measurements and/or influence of medical therapy, which could have concealed or decreased correlations for example between FGF23 and phosphate and tumor size. This evidence concerns the gene FGF23 and neoplasm.